News Diabetes app developer WellDoc attracts institutional-level investment from Super Angels – MedCity News When WellDoc was founded in 2005, it was one of the first companies that sought…Super UserOctober 22, 2013
News QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations – MarketWatch QIAGEN N.V. today announced a partnership with Clovis Oncology CLVS +1.11% to co-develop and co-commercialize…Super UserOctober 22, 2013
BHI Weekly News Archives 67th Edition – October 22, 2013 You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing this…Super UserOctober 22, 2013
News Governor O’Malley, Montgomery County Executive Leggett and City of Gaithersburg Mayor Katz Announce Expansion of Emergent BioSolutions | Governor Martin O’Malley today joined with Montgomery County Executive Isiah Leggett and City of Gaithersburg…Super UserOctober 21, 2013
News NIH ALERT: Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations This Notice is to provide NIH’s extramural community with information on how NIH is resuming…Super UserOctober 21, 2013
News Cleveland Clinic’s innovation secrets – Healthcare IT News Cleveland Clinic is in the midst of its annual Cleveland Clinic Medical Innovation Summit today…Super UserOctober 21, 2013
News AstraZeneca CEO keeping promises – The News Journal When Pascal Soriot took the reins of AstraZeneca last fall, he said he planned to…Super UserOctober 21, 2013
News Corporate venture capital is driving cutting edge medical innovation – CPI Financial The research, by Gary Dushnitsky, Associate Professor of Strategy and Entrepreneurship, London Business School and…Super UserOctober 21, 2013
News If Everyone Hates the FDA Approval Process, Let’s Fix It – Dan Ollendorf – Harvard Business Review There is one certainty about the current regulatory process for drug approval in the United…Super UserOctober 21, 2013
News 21 Red Flags to Watch for in a Biotech Company – Xconomy Nutty things are happening in biotech. Irrational exuberance has returned. Generalist investors with lots of…Super UserOctober 21, 2013